Gilles Bernard Tremblay
Director Técnico/Científico/I+D en Alethia Biotherapeutics, Inc. .
Cargos activos de Gilles Bernard Tremblay
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Alethia Biotherapeutics, Inc.
 Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Director Técnico/Científico/I+D | 01/01/2000 | - |
| Corporate Officer/Principal | 01/01/2000 | - |
Historial de carrera de Gilles Bernard Tremblay
Antiguos cargos conocidos de Gilles Bernard Tremblay.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SignalGene, Inc. | Corporate Officer/Principal | - | - |
Formación de Gilles Bernard Tremblay.
| McGill University | Doctorate Degree |
Estadísticas
Internacional
| Canadá | 4 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Health Technology |
| SignalGene, Inc. |
